PLUR
Pluri, Inc.
NASDAQ · Healthcare · Biotechnology · IL
$1.08
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.58x
- Price / sales
- 13.12x
- Price / cash flow
- -0.68x
Enterprise value
- Enterprise value
- $46.0M
- EV / sales
- 45.32x
- EV / EBITDA
- -1.92x
- EV / EBIT
- -1.85x
- Market cap
- $13.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026